Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter E Haefeli

Showing results (151-160 of 351) with videos related to

Pageof 36
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal FailureMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Psychotherapy and Psychosomatics|October 18, 2014
An N-of-1 trial as an individualized withdrawal treatment approach to psychological methylphenidate dependenceAnette Lampert, Jonas Tesarz, Anne-Katrin Volkert, et al.
Age and Ageing|November 17, 2019
Investigation of a possible association of potentially inappropriate medication for older adults and frailty in a prospective cohort study from GermanyDana Clarissa Muhlack, Liesa Katharina Hoppe, Kai-Uwe Saum, et al.
Atherosclerosis|September 24, 2004
Acute hyperhomocysteinemia decreases NO bioavailability in healthy adultsSilvana C Romerio, Lilly Linder, Jürg Nyfeler, et al.
Pharmaceutics|December 23, 2023
Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry QuantificationMax Sauter, Jonas Haag, Cindy Bay, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2017
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationDaniel Moj, Hannah Britz, Jürgen Burhenne, et al.
Deutsches Arzteblatt International|March 18, 2022
Oral Drugs Against COVID-19Gerd Mikus, Kathrin I Foerster, Theresa Terstegen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoringArwa Hassan, Jürgen Burhenne, Klaus-Dieter Riedel, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Undeclared exposure to St. John's Wort in hospitalized patientsMeret Martin-Facklam, Karin Rieger, Klaus-Dieter Riedel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2018
Reply to Truffot et alMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Pageof 36

Showing results (151-160 of 351) with videos related to

Sort By:
Pageof 36
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal FailureMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Psychotherapy and Psychosomatics|October 18, 2014
An N-of-1 trial as an individualized withdrawal treatment approach to psychological methylphenidate dependenceAnette Lampert, Jonas Tesarz, Anne-Katrin Volkert, et al.
Age and Ageing|November 17, 2019
Investigation of a possible association of potentially inappropriate medication for older adults and frailty in a prospective cohort study from GermanyDana Clarissa Muhlack, Liesa Katharina Hoppe, Kai-Uwe Saum, et al.
Atherosclerosis|September 24, 2004
Acute hyperhomocysteinemia decreases NO bioavailability in healthy adultsSilvana C Romerio, Lilly Linder, Jürg Nyfeler, et al.
Pharmaceutics|December 23, 2023
Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry QuantificationMax Sauter, Jonas Haag, Cindy Bay, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2017
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationDaniel Moj, Hannah Britz, Jürgen Burhenne, et al.
Deutsches Arzteblatt International|March 18, 2022
Oral Drugs Against COVID-19Gerd Mikus, Kathrin I Foerster, Theresa Terstegen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoringArwa Hassan, Jürgen Burhenne, Klaus-Dieter Riedel, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Undeclared exposure to St. John's Wort in hospitalized patientsMeret Martin-Facklam, Karin Rieger, Klaus-Dieter Riedel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2018
Reply to Truffot et alMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Pageof 36